April 7 (Reuters) - CSL Ltd CSL.AX:
NOTES ANNOUNCEMENT BY UNITED STATES ADMINISTRATION ON 2 APRIL
INITIAL VIEW IS THAT MOST OF CSL'S U.S. PRODUCT SALES WILL NOT BE SUBJECT TO TARIFFS
U.S. ADMINISTRATION HAS RECOGNISED UNIQUE NATURE OF PLASMA-DERIVED THERAPIES UNDER PROCLAMATION
EFFECTIVE DATE FOR ANY TARIFF IMPACTS IS 29 SEPTEMBER 2026